Your browser doesn't support javascript.
loading
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax.
Herzog, Lee-Or; Walters, Beth; Buono, Roberta; Lee, J Scott; Mallya, Sharmila; Fung, Amos; Chiu, Honyin; Nguyen, Nancy; Li, Boyang; Pinkerton, Anthony B; Jackson, Michael R; Schneider, Robert J; Ronai, Ze'ev A; Fruman, David A.
Afiliação
  • Herzog LO; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Walters B; New York University School of Medicine, New York, NY, USA.
  • Buono R; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Lee JS; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Mallya S; Genomics Institute of the Novartis Research Foundation, San Diego, CA, 92121, USA.
  • Fung A; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Chiu H; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Nguyen N; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Li B; Benaroya Research Institute, Seattle, WA, 98101, USA.
  • Pinkerton AB; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Jackson MR; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
  • Schneider RJ; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Ronai ZA; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Fruman DA; New York University School of Medicine, New York, NY, USA.
Br J Cancer ; 124(6): 1098-1109, 2021 03.
Article em En | MEDLINE | ID: mdl-33318657
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Resistencia a Medicamentos Antineoplásicos / Fator de Iniciação 4E em Eucariotos / Terapia de Alvo Molecular Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Resistencia a Medicamentos Antineoplásicos / Fator de Iniciação 4E em Eucariotos / Terapia de Alvo Molecular Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article